Header Logo

Connection

JAMES WELSH to Receptors, Immunologic

Back to Details
This is a "connection" page, showing publications JAMES WELSH has written about Receptors, Immunologic.
JAMES WELSH
Connection Strength
0.182
Receptors, Immunologic
  1. Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer. J Nanobiotechnology. 2022 Sep 19; 20(1):417.
    View in: PubMed
    Score: 0.182
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.